CO-FOUNDER CEO, IMMUNOGENX
WHY: Co-founded Newport Beach-based ImmunogenX, an early-stage developer working on clinical trials of celiac disease, in 2013. Research efforts are focused on therapy, disease management, and food safety for those adhering to a gluten-free diet.
IN THE NEWS: Said this summer that the completion of its CeliacShield trial would be published in the Gastroenterology Journal.
NOTABLE: Has published over 130 papers, delivered about 100 invited talks and has over 30 U.S. patents issued or pending. Holds a Ph.D. in physical chemistry from Brown University; regarded as a leading expert in mass spectrometry and trace chemical detection.
